期刊文献+

奥氮平与氟哌啶醇治疗女性精神分裂症患者的对照研究 被引量:1

A control study on olanzapine versus haloperidol in the treatment of female schizophrenic.
下载PDF
导出
摘要 目的比较奥氮平与氟哌啶醇治疗女性精神分裂症患者的疗效及安全性。方法将符合条件的100例住院女性精神分裂症患者随机分为奥氮平组和氟哌啶醇组,共治疗3个月,采用PANSS、TESS、健康状况问卷(SF-36)进行疗效、不良反应和生活质量评估,同时检测血清泌乳素水平。结果两组治疗前后PANSS评分均有显著性差异(P<0.01),治疗结束后阴性症状评分奥氮平组明显低于氟哌啶醇组,有显著差异(P<0.01);奥氮平组在生理机能、生理职能、生命活力、社会功能、情感职能5个因子分及生活质量总评分均明显高于氟哌啶醇组(P<0.05);治疗结束后奥氮平组泌乳素水平显著低于氟哌啶醇组(P<0.01)。结论奥氮平治疗女性精神分裂症疗效好,安全性高,生活质量优于氟哌啶醇。 Objective To compare the efficacy and safety of female schizophrenic treated with olanzapine versus chlorpromazine. Method 100 female schizophrenic were randomly divided into two groups receiving olanzapine and haloperidol respectively for 3 months, positive and negative symptom scale ( PANSS), the treatment emergent symptom scale (TESS) and Short Form 36 Health survey Questionnaire (SF -36) were used to evaluate the treatment effect,the side effects,the quality of life,and determine the serum prolactin levels. Results After treatment, the scores of PANSS of two groups were both significantly decreased ( P 〈 0. 01 ), but the scores of negative symptom of olanzapine group were lower than that of the haloperidol group, statistically significantly ( P 〈 0. 01 ). The olanzapine group were higher than the haloperidol group in the factor scores of physical functioning, role - physical, vitality, social functioning, role - emotional and the totol group in the factor scores of physical functioning role - physical,vitalityl, social functioning role - emotional and the total scores of SF - 36, with statistical significance ( P 〈 0. 05 ). After treatment, the serum prolactin levels of the olanzapine group were lower than the haloperidol group, statistically significantly ( P 〈 0. 01 ). Conclusion Olanzapine can be safely arid effectively used to treat the female schizophrenia with better life quality than haloperidol.
出处 《四川精神卫生》 2009年第1期26-29,共4页 Sichuan Mental Health
关键词 奥氮平 氟哌啶醇 女性精神分裂症 Olanzapine Haloperidol Female schizophrenia
  • 相关文献

参考文献7

  • 1Hirsehfeld MA, Montgomery SA, Keller MB, et al. Social functioning in depression:A Review [J]. J Clin Psychiatry,2000,64(4) :268 - 275.
  • 2张作记.行为医学量表手册[J].中国行为医学科学,2001,:118-119.
  • 3Tollefson GD, Birkett MA, Kiesles GM, etal. Double lind comparison of olanzapin eversus clozapin in schizophrenic patients clinical lyeligi blefor treatment with clozapine [ J ]. Biological Psychiatry, 2001,49 ( 1 ) :52 - 63.
  • 4Fanous A, Lindenmayer JP. Schizophrenia and schizoaffeetive disorder treated with high doses of olanzapine [J]. J Clin Psychopharmacol, 1999,19(3) :275 -276.
  • 5贺津,安庆华.奥氮平与氯丙嗪治疗精神分裂症比较研究[J].山东精神医学,2003,16(2):78-80. 被引量:6
  • 6任清涛,田明萍,路英智.奋乃静与利培酮对精神分裂症病人生活质量影响的比较研究[J].中国行为医学科学,2002,11(1):32-33. 被引量:14
  • 7汪衡华 李宁 黄建民 等.门诊精神分裂症患者生活质量及其影响因素[J].国际中华神经精神医学杂志,2002,3:101-103.

二级参考文献8

  • 1李凌江,张亚林,杨德森,郝伟,肖水源,李振国,廖巨福,吴舸,罗友根,黄俊,张斌,刘解宁.社区人群生活质量研究──Ⅱ方法学及社区人群的总体生活质量[J].中国心理卫生杂志,1995,9(4):186-190. 被引量:220
  • 2Tollefson G D, Beasley C Je, Tancera R N, et al. Blind,controlled, longterm study of the comparative incidence of treatmentemergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry, 1997,154: 1248- 1254.
  • 3Beasley C M, Tollefson G D, Tran P V . Efficacy of danzapine.. An overview of pivotal clinical trials. J Clin Psychiatry, 1977,58 (suppl) :7.
  • 4Balswin D S, Montgomery S A. First clinical experience with olanzapine ( L Y 170053) : results of an open-lable safety and doseranging study in patients with schizophrenia. Int Clin Psychophamacle, 1955,10:239-244.
  • 5陈文 蓝光华 等.奥氮平临床应用14例观察小结[J].临床精神医学杂志,1999,9:318-318.
  • 6中华医学会精神科学会.中国精神疾病分类和诊断标准(CCMD-2-R)[M].南京:东南大学出版社,1995.69-70.
  • 7郑洪波,邓河晃,周亮.奥氮平维持治疗精神分裂症23例临床评价[J].上海精神医学,2000,12(1):43-44. 被引量:7
  • 8吴彩云,吴爱勤,李华杰,赵海园.奥氮平治疗精神病性障碍36例初步观察[J].上海精神医学,2000,12(1):45-46. 被引量:48

共引文献980

同被引文献13

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部